Kingsley 2009.
Methods | This was a multicentre, randomised, double‐blind, placebo‐controlled trial, which lasted 6 months (the MIPA (methotrexate in active psoriatic arthritis) trial). The trial conducted intention‐to‐treat analysis. |
Participants |
Inclusion criteria of the trial
|
Interventions |
|
Outcomes |
Outcomes of the trial
|
Notes | The trial reported dropouts. This was a conference publication. |